An -GlcNAcylomic Approach Reveals ACLY as a Potential Target in Sepsis in the Young Rat.

Sepsis in the young population, which is particularly at risk, is rarely studied. -GlcNAcylation is a post-translational modification involved in cell survival, stress response and metabolic regulation. -GlcNAc stimulation is beneficial in adult septic rats. This modification is physiologically higher in the young rat, potentially limiting the therapeutic potential of -GlcNAc stimulation in young septic rats. The aim is to evaluate whether -GlcNAc stimulation can improve sepsis outcome in young rats. Endotoxemic challenge was induced in 28-day-old rats by lipopolysaccharide injection ( O111:B4, 20 mg·kg) and compared to control rats (NaCl 0.9%). One hour after lipopolysaccharide injection, rats were randomly assigned to no therapy, fluidotherapy (NaCl 0.9%, 10 mL·kg) ± NButGT (10 mg·kg) to increase -GlcNAcylation levels. Physiological parameters and plasmatic markers were evaluated 2h later. Finally, untargeted mass spectrometry was performed to map cardiac -GlcNAcylated proteins. Lipopolysaccharide injection induced shock with a decrease in mean arterial pressure and alteration of biological parameters ( < 0.05). NButGT, contrary to fluidotherapy, was associated with an improvement of arterial pressure ( < 0.05). ATP citrate lyase was identified among the -GlcNAcylated proteins. In conclusion, -GlcNAc stimulation improves outcomes in young septic rats. Interestingly, identified -GlcNAcylated proteins are mainly involved in cellular metabolism.